ABCG2 and cancer: The fact that oncogenic stress leads to systemic upregulation of BCRP has broad consequences and sheds new light on the origin of MDR, in particular the primary type, i.e., the drug resistance that develops in cancer before any therapeutic treatments or selective pressures are applied.